Name | BIOPROTSESS-KHOLDING, OOO |
|---|
INN | 7703372990 |
|---|
KPP | 770301001 |
|---|
OGRN | 1037703029870 |
|---|
OKPO | 70103204 |
|---|
Address | 121069, G.moskva, per. Stolovyy, d. D. 6 |
|---|
Phone | 974-74-01 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 64.99 | Core activity | Provision of other financial services nec |
Registration date | 20.06.2003 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram N3 po Tsentral'nomu administrativnomu okrugu g.Moskvy |
|---|
|
BIOPROTSESS-KHOLDING, OOO (Moscow; INN 7703372990) was registered on 20 Jun 2003. The company's authorized capital as of July 1, 2012 was 22000000 rub. Type of ownership of BIOPROTSESS-KHOLDING, OOO - Limited liability companies. Form of ownership of BIOPROTSESS-KHOLDING, OOO - Combines private and foreign property. Principal activities of BIOPROTSESS-KHOLDING, OOO: provision of other financial services nec (64.99). |
Economic indicators2023
Net loss (RAS) of BIOPROTSESS-KHOLDING, OOO increased 15.97 times to 11.03 million RUB from 691.00 thousand RUB over 2022, the company informed. Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 337.00 thousand RUB in 2022. 2022
Net loss (RAS) of BIOPROTSESS-KHOLDING, OOO dropped over 2022 16.51 times to 691.00 thousand RUB from 11.41 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 37.94% to 337.00 thousand RUB from 543.00 thousand RUB in 2021. 2021
Net loss (RAS) of BIOPROTSESS-KHOLDING, OOO dropped over 2021 6.93 times to 11.41 million RUB from 79.11 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period 2.26 times to 543.00 thousand RUB from 1.23 million RUB in 2020. 2020
Net loss (RA) of BIOPROTSESS-KHOLDING, OOO made up 79.11 million RUB over 2020 compared to net profit of 59.02 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 13.35% to 1.23 million RUB from 1.42 million RUB in 2019. 2019
Net profit (RAS) of BIOPROTSESS-KHOLDING, OOO made up 59.02 million RUB over 2019 compared to net loss of 22.05 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 10.33% to 1.42 million RUB from 1.58 million RUB in 2018; cost of goods sold grew 18.97 times to 6.01 million RUB from 317.00 thousand RUB; sales loss decreased by 14.59% to 33.95 million RUB from 39.75 million RUB. 2018
Net loss (RAS) of BIOPROTSESS-KHOLDING, OOO dropped over 2018 9.24 times to 22.05 million RUB from 203.82 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period 2.32 times to 1.58 million RUB from 3.67 million RUB in 2017; cost of goods sold decreased 18.80 times to 317.00 thousand RUB from 5.96 million RUB; sales loss grew by 2.15% to 39.75 million RUB from 38.92 million RUB. 2017
Net loss (RA) of BIOPROTSESS-KHOLDING, OOO made up 203.82 million RUB over 2017 compared to net profit of 33.22 million RUB over 2016, the company informed. Revenue decreased in the accounting period 6.97 times to 3.67 million RUB from 25.55 million RUB in 2016; cost of goods sold decreased by 16.01% to 5.96 million RUB from 7.10 million RUB; sales loss grew 1.69 times to 38.92 million RUB from 22.99 million RUB. 2016
Net profit (RAS) of BIOPROTSESS-KHOLDING, OOO made up 33.22 million RUB over 2016 compared to net loss of 5.71 million RUB over 2015, the company informed. Revenue increased in the accounting period 3.95 times to 25.55 million RUB from 6.47 million RUB over 2015; cost of goods sold grew 2.99 times to 7.10 million RUB from 2.38 million RUB; sales loss decreased by 28.00% to 22.99 million RUB from 31.92 million RUB. 2014
Net loss (RA) of Bioprotsess-kholding, OOO made up 7.60 million RUB over 2014 compared to net profit of 98.31 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 44.59% to 4.02 million RUB from 7.25 million RUB in 2013; cost of goods sold decreased 17.27 times to 1.02 million RUB from 17.67 million RUB; sales loss decreased by 32.12% to 30.59 million RUB from 45.07 million RUB. 2013
Net profit (RAS) of Bioprotsess-kholding, OOO grew over 2013 5.45 times to 98.31 million RUB from 18.03 million RUB over 2012, the company informed. Revenue decreased in the accounting period by 44.66% to 7.25 million RUB from 13.11 million RUB in 2012; cost of goods sold decreased 3.70 times to 17.67 million RUB from 65.33 million RUB; sales loss decreased by 47.93% to 45.07 million RUB from 86.55 million RUB. 2012
Net profit (RAS) of Bioprocess-kholding, OOO made up 18.03 million RUB over 2012 compared to net loss of 71.59 million RUB over 2011, the company informed. Revenue decreased in the accounting period 4.00 times to 13.11 million RUB from 52.44 million RUB in 2011; cost of goods sold decreased by 5.66% to 65.33 million RUB from 69.26 million RUB; sales loss grew 1.80 times to 86.55 million RUB from 48.16 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|